|
⚲
|
| Keyboard |
| Warner Brent
✚
|
|
|---|---|
| CIK # | 0001910914 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001910914] | |
| 4 | [0001910914] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Poseida Therapeutics Inc | |
| Warner Brent |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-03-01 | Tax withheld | 35,739 | $4.13 | 147,602 |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2024-03-01 | Grant | 80,743 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Employee Stock Option (Right to Buy) · derivative
|
2024-03-01 | Grant | 111,700 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Stock Option (Right to Buy) · derivative
|
2023-03-01 | Grant | 125,283 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2023-03-01 | Grant | 92,772 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2023-03-01 | Tax withheld | 26,617 | $5.35 | 142,401 |
|
Poseida Therapeutics Inc PSTX
Stock Option (Right to Buy) · derivative
|
2022-03-01 | Grant | 431,034 | $0.00 | |
|
Poseida Therapeutics Inc PSTX
Common Stock
|
2022-03-01 | Grant | 307,881 | $0.00 |